Last edition
News about "Antitussive efficacy"
Addex Therapeutics Reports Promising Preclinical Results for Novel Chronic Cough Therapy
Addex Therapeutics’ experimental GABAB modulator shows potential as a well-tolerated, long-term treatment option for chronic cough, addressing a significant unmet need in idiopathic pulmonary fibrosis patients.
Antitussive Efficacy | 04/05/2026 | By News Bureau
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy
pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members